Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTENE CORPCNC · Entity 3133 | Group President, Markets&Comm | May 12, 2026 | May 18, 2026 |
| CVS HEALTH CorpCVS · Entity 2884 | EVP/Pres, Health Care Benefits | April 01, 2023 | April 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTENE CORP
Report date May 12, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 228,127 |
Reported balance
Holding disclosure · report date 2026-05-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 228,127 F1: Ownership includes 228,127 restricted stock units subject to vesting in three equal installments on the anniversary of the grant date beginning April 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership includes 228,127 restricted stock units subject to vesting in three equal installments on the anniversary of the grant date beginning April 15, 2027.
CVS HEALTH Corp
Report date April 01, 2023 · Filed April 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,067.8088 |
Reported balance
After 2023-04-01 transaction · row 1
1 source rowRow 1 · 2023-04-01 · Tax withholding · Disposed 3,856 · Balance 35,067.8088 F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.31 · Expires 2033-04-01 | Direct | 74,228 |
Reported balance
After 2023-04-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-04-01 · Grant · Acquired 74,228 · Balance 74,228 F7: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 16,161 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 16,161 F2: Option became exercisable in four equal annual installments, beginning on 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 27,166 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 27,166 F3: Option became exercisable in four equal annual installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 82,066 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 82,066 F4: Option became exercisable in four equal annual installments, commencing 4/1/2022. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $52.37 · Expires 2029-05-31 | Direct | 19,094 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 19,094 F5: Option became exercisable in three equal annual installments, commencing 5/31/2022. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $101.09 · Expires 2032-04-01 | Direct | 51,975 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 51,975 F6: Option became exercisable in four equal annual installments, commencing 4/1/2023. |
| Common Stock (pep)SEC Table I · non-derivative | Direct | 3,173.3157 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,173.3157 |
| Common Stock (Restricted)SEC Table I · non-derivative | Direct | 6,107 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,107 |
| Stock Unit (deferred)SEC Table I · non-derivative | Direct | 3,173.3157 |
Reported balance
Holding disclosure · report date 2023-04-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,173.3157 |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
F2: Option became exercisable in four equal annual installments, beginning on 4/1/2020.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2021.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2022.
F5: Option became exercisable in three equal annual installments, commencing 5/31/2022.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2023.
F7: Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2023 Filed Apr 4, 2023 20:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 74,228 | $74.31 Strike: $74.31 | $5,515,882.68 |
DisclosureSEC source: 0001127602-23-012221 · form4.xml · derivative · entry 10 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,228 Underlying: Common Stock · 74,228 shares Expires 2033-04-01 F7 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,856 | $74.31 | $286,539.36 |
DisclosureSEC source: 0001127602-23-012221 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,067.8088 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 9,546 | $0.00 Strike: $52.37 | $0.00 |
DisclosureSEC source: 0001127602-22-020590 · form4.xml · derivative · entry 6 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,094 Underlying: Common Stock · 9,546 shares Expires 2029-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 5/31/2022. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 9,546 | $100.00 | $954,600.00 |
DisclosureSEC source: 0001127602-22-020590 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,149.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 9,546 | $52.37 | $499,924.02 |
DisclosureSEC source: 0001127602-22-020590 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,695.9607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,941 | $100.00 | $594,100.00 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 6 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,149.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 27,166 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · derivative · entry 11 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,166 Underlying: Common Stock · 27,166 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 16,161 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · derivative · entry 10 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,161 Underlying: Common Stock · 16,161 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, beginning on 4/1/2020. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 12,032 | $100.13 | $1,204,764.16 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 5 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,090.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 27,166 | $100.13 | $2,720,131.58 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 4 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,122.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 27,166 | $58.34 | $1,584,864.44 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 3 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,288.9607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 16,161 | $100.13 | $1,618,200.93 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,122.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 16,161 | $54.19 | $875,764.59 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,283.9607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 51,975 | $101.09 Strike: $101.09 | $5,254,152.75 |
DisclosureSEC source: 0001127602-22-011602 · form4.xml · derivative · entry 7 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,975 Underlying: Common Stock · 51,975 shares Expires 2032-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,856 | $101.09 | $389,803.04 |
DisclosureSEC source: 0001127602-22-011602 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,122.9607 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 21:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 13,532 | $101.09 | $1,367,949.88 |
DisclosureSEC source: 0001127602-22-011602 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,181.9607 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006288 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,713.9607 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 32,320 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-21-019437 · form4.xml · derivative · entry 5 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,322 Underlying: Common Stock · 32,320 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, beginning on 4/1/2020. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 37,594 | $86.60 | $3,255,640.40 |
DisclosureSEC source: 0001127602-21-019437 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,309.5841 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 32,320 | $54.19 | $1,751,420.80 |
DisclosureSEC source: 0001127602-21-019437 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,903.5841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 82,066 | $74.30 Strike: $74.30 | $6,097,503.80 |
DisclosureSEC source: 0001127602-21-012728 · form4.xml · derivative · entry 6 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,066 Underlying: Common Stock · 82,066 shares Expires 2031-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 4,540 | $74.30 | $337,322.00 |
DisclosureSEC source: 0001127602-21-012728 · form4.xml · nonDerivative · entry 3 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,565.1519 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,044 | $74.30 | $449,069.20 |
DisclosureSEC source: 0001127602-21-012728 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,309.1519 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 22:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,413 | $68.94 | $166,352.22 |
DisclosureSEC source: 0001127602-21-008848 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,073.1519 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 01, 2021 Filed Apr 2, 2021 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 14,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012728 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,079.1519 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.